GLORIA MAYS: Open Payments
NPI 1194746362 · RUSTON, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$502 in 8 payments from 6 companies in 2025. Trend: 2023 $142 · 2024 $227 · 2025 $502
Food & beverage: $502
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 3 | $153 |
| Astellas Pharma US Inc | 1 | $120 |
| Otsuka America Pharmaceutical, Inc. | 1 | $116 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $81 |
| Alpha Cognition USA, Inc. | 1 | $17 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
Products named: INVEGA SUSTENNA, Veozah, REXULTI, CAPLYTA, Zunveyl, COBENFY.
Industry payments across LA — which companies pay providers there.
